Crohn’s Disease Therapeutics Market
Crohn’s Disease Therapeutics Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Crohn’s Disease Therapeutics Market Size and Growth
The Crohn’s Disease Therapeutics market is experiencing steady growth due to increasing prevalence of the disease and advancements in treatment options. The market size is estimated to be $7.6 billion by 2025, with biologics leading the category. Key players are focusing on developing targeted therapies to cater to the unmet needs of patients.
Sample Report
Request
Companies Covered (Covid 19 Impact Covered)
◍ Johnson and Johnson Services Inc.
◍ Pfizer Inc.
◍ Allergan
◍ AbbVie Inc.
The competitive landscape of Crohn's Disease Therapeutics Market is highly competitive with key players like Johnson & Johnson, Pfizer, AbbVie, and Takeda Pharmaceutical dominating the market. These companies offer a range of treatments such as biologics, immunosuppressants, and anti-inflammatory drugs to manage Crohn's Disease.
◍ Takeda Pharmaceutical Company Limited
◍ Celgene Corporation
◍ Perrigo Company PLC
◍ Ferring B.V.
◍ Salix Pharmaceuticals
◍ Gilead Sciences Inc.
◍ Genentech Inc.
◍ UCB India Private Limited.
- Johnson and Johnson Services Inc. reported sales revenue of $81.6 billion in 2020.
- Pfizer Inc. reported sales revenue of $51.8 billion in 2020.
- AbbVie Inc. reported sales revenue of $45.8 billion in 2020. These companies invest in research and development, strategic partnerships, and acquisitions to enhance their product portfolio and expand their market presence in the Crohn's Disease Therapeutics Market, thereby contributing to its growth.
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Ambulatory Surgical Centers
By Product
◍ Non-Surgical
◍ Surgical
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients